Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

Abstract

The findings of significant relationships between treatment-emergent weight gain and improvements in clinical and functional status at 6-weeks suggest that patients who have greater treatment-emergent weight gain are more likely to benefit from treatment with olanzapine or haloperidol regardless of gender.